This trial is testing a new drug, belzutifan, in people with end stage renal disease. The study will look at how well the body processes the drug and how safe and tolerable it is.
- Kidney Failure
5 Primary · 3 Secondary · Reporting Duration: Predose, and at 0.5, 1, 1.5, 2, 3, 4, 5, 6, 9, 12, 24, 36, 48, and 72 hours postdose
Awards & Highlights
2 Treatment Groups
Belzutifan in Participants with ESRD
1 of 2
Belzutifan in Healthy Participants
1 of 2
12 Total Participants · 2 Treatment Groups
Primary Treatment: Belzutifan · No Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Age 18 - 75 · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does this trial include persons aged 55 and above?
"This research is open to individuals that are at least 18 years old and younger than 75." - Anonymous Online Contributor
How many participants are being monitored in this experiment?
"Affirmative. The details posted on clinicaltrials.gov attest to the fact that this medical study, whose initial posting was July 12th 2022, is actively seeking participants. Precisely 12 patients must be enrolled from one healthcare facility." - Anonymous Online Contributor
Has Belzutifan been verified by the FDA?
"Belzutifan's safety is estimated to be a 1 given that this is an early-stage clinical trial with limited evidence of efficacy and associated risk." - Anonymous Online Contributor
Has there been any prior experimentation with this particular clinical study?
"Presently, 16 clinical trials for Belzutifan are ongoing in 372 cities across 44 nations. The initial study sponsored by Peloton Therapeutics, Inc., began in 2016 and involved 120 participants who completed the Phase 1 drug approval process. Since that time, one additional trial has been concluded." - Anonymous Online Contributor
Are there any prior studies that have used Belzutifan to explore treatment options?
"Presently, 16 different medical trials are being conducted on Belzutifan. 3 of these active studies are in the final Phase before approval. Whilst most research is taking place at Cardiff, Wales, there are 859 total clinical trial sites operating experiments pertaining to this medication." - Anonymous Online Contributor
To what extent has Belzutifan been found to be efficacious in treating patients?
"Belzutifan is a viable treatment option for malignant neoplasms, anemia, sickle cell illness, and von hippel lindau disease." - Anonymous Online Contributor
Are there any qualifications I must meet to participate in this clinical experiment?
"In order to be accepted in this study, those aged between 18 and 75 should present with renal failure. This trial is taking on 12 participants in total." - Anonymous Online Contributor
Are there any current vacancies for participants in this medical experiment?
"As per the data on clinicaltrials.gov, this medical trial is currently searching for suitable individuals to take part in the study. The details of which have been available since July 12th 2022 and were last updated a week later." - Anonymous Online Contributor